Clinical Trials Logo

Clinical Trial Summary

The purpose is to understand the clinical characteristics of chronic heart failure as soon as possible, analyze the etiology, comorbidities, clinical characteristics, and treatment of heart failure patients, observe the gap between real-world clinical practice and guideline recommendations, and provide reference for the improvement of heart failure prevention and treatment in China.


Clinical Trial Description

Inclusion criteria: 1. Accompanied by difficulty breathing, fatigue, or decreased activity tolerance; 2. Signs of fluid retention (pulmonary congestion and peripheral edema); 3. Echocardiography shows abnormalities in cardiac structure and/or function; 4. Elevated levels of natriuretic peptide: B-type natriuretic peptide (BNP)>35 ng/L and/or N-terminal B-type proBNP (NT proBNP)>125 ng/L. 5. HF hospitalization recorded within the previous 12 months Exclusion criteria: 1. Concomitant severe liver function, renal failure, or other severe system dysfunction 2. Poor compliance, inability to obtain information, or voluntary refusal to participate in this study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06092658
Study type Observational
Source Xinjiang Medical University
Contact
Status Completed
Phase
Start date November 20, 2012
Completion date July 14, 2022